2/20/25 (LAPost.com) — New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption. The study, published in JAMA ...

A HIGHER ‘golden dose’ of Wegovy than is currently approved is safe and could be more effective – helping patients lose ...

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new research led by Christian ...

(NEW YORK) — Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit — it could help people drink less alcohol. A study published in JAMA Psychiatry ...

A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential for novel treatments pending further clinical ...

Phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving. (HealthDay News) — Low-dose semaglutide seems to reduce craving and certain drinking outcomes in ...

"This is the first trial showing semaglutide's potential as a drug for cocaine dependence," said study author and ...

IT’S not only stubborn fat that weight loss jabs can bust, but cocaine addiction, according to a new study. Semaglutide, sold ...

Scientists have found that the diabetes/weight loss drug semaglutide, sold commercially under brand names like Ozempic and ...